Skip to main content
. 2017 Jun 14;103(5):464–474. doi: 10.5301/tj.5000649

Fig. 2.

Fig. 2

Active treatment-free survival (ATFS) stratified by causes of discontinuation from active surveillance. Kaplan-Meier curves for ATFS according to whether discontinuation of active surveillance was related to biopsy findings (A), prostate-specific antigen doubling time (DT) (B), or patient anxiety (C). Continuous and dotted lines represent actuarial survival and 95% confidence intervals, respectively.